XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Cash flows for operating activities:      
Net loss $ (9,981,105) $ (16,891,148) $ (11,917,500)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 376,932 523,756 578,666
Intangible asset impairment 192,500    
Stock-based compensation 837,040 1,184,570 2,132,835
Inventory charges 98,556 2,075,494 363,902
Warrants fair value adjustment     5,175,136
Changes in operating assets and liabilities:      
Accounts receivable 682,846 1,733,767 103,123
Inventories 550,549 71,308 683,298
Prepaid expenses and other current assets 110,400 (199,105) (90,921)
Accounts payable 370,060 (827,791) 885,671
Legal settlement     (3,705,866)
Accrued expenses and compensation 240,433 (753,995) (120,035)
Deferred revenue, deferred costs, and other (256,609) (223,970) (225,396)
Net cash used in operating activities (6,778,398) (13,307,114) (6,137,087)
Cash flows for investing activities:      
Purchases of investments     (7,495,000)
Maturities of investments   7,495,000 7,495,000
Purchases of fixed assets (110,987) (306,451) (342,115)
Purchase of technological and intellectual property     (350,000)
Release of restricted cash 178,500    
Net cash provided by (used in) investing activities 67,513 7,188,549 (692,115)
Cash flows from financing activities:      
Net proceeds from issuance of common stock and warrants, including private placement and equity plans 33,614 195,679 17,486,849
Payments on capital lease (19,092) (27,715) (22,521)
Net cash provided by financing activities 14,522 167,964 17,464,328
Net (decrease) increase in cash and cash equivalents (6,696,363) (5,950,601) 10,635,126
Cash and cash equivalents, beginning of year 16,986,809 22,937,410 12,302,284
Cash and cash equivalents, end of year 10,290,446 16,986,809 22,937,410
Supplemental disclosure of cash flow information:      
Equipment acquired under capital lease, net   60,410  
Common stock issued to consultants     97,500
Warrants issued in Securities Purchase Agreement     $ 14,496,627